Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $1.6600 (1.22%) ($1.6600 - $1.6600) on Thu. Nov. 11, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.55% (three month average) | RSI | 17 | Latest Price | $1.6600(1.22%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -8.1% a day on average for past five trading days. | Weekly Trend | ANPC declines -12.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) EMHY(21%) JNK(20%) EWG(19%) IDRV(18%) LIT(18%) | Factors Impacting ANPC price | ANPC will decline at least -3.275% in a week (0% probabilities). SLV(-23%) SIL(-23%) UUP(-18%) GDX(-18%) GDXJ(-17%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.275% (StdDev 6.55%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-21.6(-1401.2%) | Resistance Level | $2.59 | 5 Day Moving Average | $2.16(-23.15%) | 10 Day Moving Average | $2.37(-29.96%) | 20 Day Moving Average | $2.59(-35.91%) | To recent high | -52.3% | To recent low | 1.2% | Market Cap | $14m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |